Loading clinical trials...
Loading clinical trials...
A Phase I Safety and Immunogenicity Trial of Recombinant HIV-1 Tat Protein in HIV-1 Uninfected Adult Volunteers
Conditions
Interventions
Biologically active recombinant Tat protein
Locations
4
Italy
San Raffaele Hospital
Milan, Italy
Hospital Spallanzani
Rome, Italy
San Gallicano Hospital
Rome, Italy
University of Rome "La Sapienza"
Rome, Italy
Start Date
January 1, 2004
Completion Date
November 1, 2007
Last Updated
March 1, 2011
NCT04142047
NCT06694805
NCT07428330
NCT07225530
NCT06665646
NCT05897099
Lead Sponsor
Istituto Superiore di Sanità
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions